These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31626221)

  • 1. [The use of the concentrate of nucleus containing cells of umbilical cord blood for treatment of asthenic disorders (schizoasthenia) in patients with schizophrenia with negative symptoms].
    Ivanov SV; Kharkova GS; Smulevich AB; Morozova YV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):68-73. PubMed ID: 31626221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Asthenic disorders in schizophrenia (schizoasthenia) on the model of hypochondriac schizophrenia].
    Ivanov SV; Kharkova GS; Giatsintova AA; Voronova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):7-12. PubMed ID: 33728844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Asthenia in the psychopathological space of schizophrenia and schizophrenia spectrum disorders (The concept of asthenic deficit in aspect of the modern model of negative symptoms)].
    Smulevich AB; Kharkova GS; Lobanova VM; Voronova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):7-14. PubMed ID: 31317883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy optimization of asthenic disorders in remissions in patients with paroxysmal-progressive schizophrenia (a clinical and immunological analysis)].
    Zozulya SA; Oleichik IV; Yakimets AV; Klyushnik TP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):64-74. PubMed ID: 32678550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human allogeneic AB0/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy.
    Romanov YA; Tarakanov OP; Radaev SM; Dugina TN; Ryaskina SS; Darevskaya AN; Morozova YV; Khachatryan WA; Lebedev KE; Zotova NS; Burkova AS; Sukhikh GT; Smirnov VN
    Cytotherapy; 2015 Jul; 17(7):969-78. PubMed ID: 25791070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of asthenic disorders after psychotic conditions in patients with cognitive impairment: results of an observational non-interventional program].
    Chubarovsky VV; Vanchakova NP; Zun SA; Parashchenko AF; Kolyago OO; Potapov IV; Savchenkov VA; Ushkalova AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(10):81-87. PubMed ID: 37966444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamics of clinical and biological indices of the asthenic symptom-complex during immunotropic therapy of patients with schizophrenia].
    Yakimets AV; Zozulya SA; Oleichik IV; Klyushnik TP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(3):70-76. PubMed ID: 29652309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Positive changes in the severity of residual psychotic symptoms in schizophrenic patients switched to treatment with risperidone].
    Burminskiy DS; Morozova MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(4):23-27. PubMed ID: 28617374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms.
    Xiao S; Xue H; Li G; Yuan C; Li X; Chen C; Wu HZ; Mitchell P; Zhang M
    Aust N Z J Psychiatry; 2012 Feb; 46(2):153-60. PubMed ID: 22311531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of multicenter study of efficacy and safety of divaza in the treatment of the asthenic and mild to moderate cognitive disorders in elderly and senile subjects].
    Parfenov VА; Kamchatnov PR; Vorobyova ОV; Gustov АV; Glushkov КS; Doronina ОB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):43-50. PubMed ID: 29053120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded umbilical cord blood T cells used as donor lymphocyte infusions after umbilical cord blood transplantation.
    Berglund S; Gertow J; Uhlin M; Mattsson J
    Cytotherapy; 2014 Nov; 16(11):1528-1536. PubMed ID: 25231890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
    Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale-supportive analyses from a Phase 3 study.
    Citrome L; Risinger R; Cutler AJ; Du Y; Zummo J; Nasrallah HA; Silverman BL
    CNS Spectr; 2018 Aug; 23(4):284-290. PubMed ID: 28625204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunct transcranial direct current stimulation improves cognitive function in patients with schizophrenia: A double-blind 12-week study.
    Jeon DW; Jung DU; Kim SJ; Shim JC; Moon JJ; Seo YS; Jung SS; Seo BJ; Kim JE; Oh M; Kim YN
    Schizophr Res; 2018 Jul; 197():378-385. PubMed ID: 30955702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.
    Boggs DL; Surti T; Gupta A; Gupta S; Niciu M; Pittman B; Schnakenberg Martin AM; Thurnauer H; Davies A; D'Souza DC; Ranganathan M
    Psychopharmacology (Berl); 2018 Jul; 235(7):1923-1932. PubMed ID: 29619533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium nitroprusside treatment for psychotic symptoms and cognitive deficits of schizophrenia: A randomized, double-blind, placebo-controlled trial.
    Wang X; Zhao J; Hu Y; Jiao Z; Lu Y; Ding M; Kou Y; Li B; Meng F; Zhao H; Li H; Li W; Yang Y; Lv L
    Psychiatry Res; 2018 Nov; 269():271-277. PubMed ID: 30170285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of the α7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers.
    Haig GM; Wang D; Zhao J; Othman AA; Bain EE
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 28922590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.